MAXHEALTH.NSMAXHEALTH.NSNSE
Loading
EBITDA Margin Over TimeStrong
Percentile Rank82
3Y CAGR+2.7%
5Y CAGR+25.9%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+2.7%/yr
vs +37.6%/yr prior
5Y CAGR
+25.9%/yr
Recent deceleration
Acceleration
-34.9pp
Decelerating
Percentile
P82
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
202526.05%-5.0%
202427.41%+2.3%
202326.80%+11.4%
202224.04%+54.8%
202115.53%+88.2%
20208.25%-8.2%
20198.99%+34.1%
20186.70%-23.6%
20178.77%+28.5%
20166.83%-